Effect of resveratrol and some other natural compounds on tyrosine kinase activity and on cytolysis
- PMID: 10370868
Effect of resveratrol and some other natural compounds on tyrosine kinase activity and on cytolysis
Abstract
Resveratrol is a phytoalexin with several biological and pharmacological activities including the "French paradox". We investigated the effect of resveratrol on cytolytic activity by oxygen reactive species and on soluble and particulate tyrosine kinases from human placenta and human prostatic adenoma. These effects were compared with those of piceatannol, quercetin, catechin and epicatechin. Fifty percent of erythrocyte lysis due to H2O2-lactoperoxidase-KI incubation, in which I3-, OI- and oxygen singlet are produced, was obtained after 22 +/- 7 (SD) min in the absence of the tested compounds. The 50% lysis was obtained after 66 +/- 15, 129 +/- 35, 196 +/- 21, 240 +/- 63 and 420 +/- 80 min with 40 microM piceatannol, quercetin, resveratrol, epicatechin and catechin respectively. Protection was concentration dependent. The assay of tyrosine kinase activity was performed using two different substrates as follows: substrate A corresponded to the sequence 1-17 of gastrin, and substrate B to sequence 6-20 of cell division kinase p34cdc2. In all experiments, initial velocity was measured. When assayed with both substrates, tyrosine kinase activities from particulate and cytosolic fractions of placenta were more inhibited by piceatannol and quercetin. Resveratrol significantly inhibited the particulate fraction and the cytosolic fraction respectively when substrates A and B were employed: Catechin acted as an inhibitor with substrate A and particulate fraction while in the other experimental conditions it acted as an activator. Resveratrol inhibited the tyrosine kinase of particulate and cytosolic fractions of prostatic adenoma assayed with substrate A and B.
Similar articles
-
Effect of resveratrol and catechin on PC12 tyrosine kinase activities and their synergistic protection from beta-amyloid toxicity.Drugs Exp Clin Res. 2003;29(5-6):243-55. Drugs Exp Clin Res. 2003. PMID: 15134381
-
Stilbene compounds: from the grapevine to wine.Drugs Exp Clin Res. 1999;25(2-3):57-63. Drugs Exp Clin Res. 1999. PMID: 10370866 Review.
-
Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase.Circulation. 2002 Sep 24;106(13):1652-8. doi: 10.1161/01.cir.0000029925.18593.5c. Circulation. 2002. PMID: 12270858
-
Antioxidant effect of trans-resveratrol, pterostilbene, quercetin and their combinations in human erythrocytes in vitro.Plant Foods Hum Nutr. 2010 Mar;65(1):57-63. doi: 10.1007/s11130-010-0154-8. Plant Foods Hum Nutr. 2010. PMID: 20108046
-
Chemotherapeutic potential of the chemopreventive phytoalexin resveratrol.Drug Resist Updat. 2004 Dec;7(6):333-44. doi: 10.1016/j.drup.2004.11.001. Epub 2004 Dec 19. Drug Resist Updat. 2004. PMID: 15790544 Review.
Cited by
-
Inhibitory effects of genistein and resveratrol on guinea pig gallbladder contractility in vitro.World J Gastroenterol. 2008 Aug 21;14(31):4955-60. doi: 10.3748/wjg.14.4955. World J Gastroenterol. 2008. PMID: 18756606 Free PMC article.
-
Inhibition of lipopolysaccharide-induced interferon regulatory factor 3 activation and protection from septic shock by hydroxystilbenes.Shock. 2004 May;21(5):470-5. doi: 10.1097/01.shk.0000123513.13212.83. Shock. 2004. PMID: 15087825 Free PMC article.
-
Nutrition, sirtuins and aging.Genes Nutr. 2006 Jun;1(2):85-93. doi: 10.1007/BF02829950. Genes Nutr. 2006. PMID: 18850202 Free PMC article.
-
Towards resolving the enigma of the dichotomy of resveratrol: cis- and trans-resveratrol have opposite effects on TyrRS-regulated PARP1 activation.Geroscience. 2021 Jun;43(3):1171-1200. doi: 10.1007/s11357-020-00295-w. Epub 2020 Nov 27. Geroscience. 2021. PMID: 33244652 Free PMC article.
-
Red wine polyphenols increase calcium in bovine aortic endothelial cells: a basis to elucidate signalling pathways leading to nitric oxide production.Br J Pharmacol. 2002 Mar;135(6):1579-87. doi: 10.1038/sj.bjp.0704603. Br J Pharmacol. 2002. PMID: 11906973 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous